Maccura Biotechnology (China) Performance
| 300463 Stock | 12.35 0.15 1.23% |
The company secures a Beta (Market Risk) of 0.18, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Maccura Biotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Maccura Biotechnology is expected to be smaller as well. At this point, Maccura Biotechnology has a negative expected return of -0.15%. Please make sure to verify Maccura Biotechnology's mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Maccura Biotechnology performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Maccura Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
| Begin Period Cash Flow | 564.3 M |
Maccura |
Maccura Biotechnology Relative Risk vs. Return Landscape
If you would invest 1,366 in Maccura Biotechnology Co on November 1, 2024 and sell it today you would lose (131.00) from holding Maccura Biotechnology Co or give up 9.59% of portfolio value over 90 days. Maccura Biotechnology Co is generating negative expected returns and assumes 1.6952% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Maccura, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Maccura Biotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Maccura Biotechnology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Maccura Biotechnology Co, and traders can use it to determine the average amount a Maccura Biotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0875
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 300463 |
Estimated Market Risk
| 1.7 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Maccura Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Maccura Biotechnology by adding Maccura Biotechnology to a well-diversified portfolio.
Maccura Biotechnology Fundamentals Growth
Maccura Stock prices reflect investors' perceptions of the future prospects and financial health of Maccura Biotechnology, and Maccura Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Maccura Stock performance.
| Return On Equity | 0.0485 | ||||
| Return On Asset | 0.0219 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 7.37 B | ||||
| Shares Outstanding | 612.47 M | ||||
| Price To Book | 1.16 X | ||||
| Price To Sales | 2.77 X | ||||
| Revenue | 2.9 B | ||||
| EBITDA | 613.34 M | ||||
| Total Debt | 144.65 M | ||||
| Book Value Per Share | 10.79 X | ||||
| Cash Flow From Operations | 901.51 M | ||||
| Earnings Per Share | 0.53 X | ||||
| Total Asset | 8.12 B | ||||
| Retained Earnings | 3.84 B | ||||
About Maccura Biotechnology Performance
By analyzing Maccura Biotechnology's fundamental ratios, stakeholders can gain valuable insights into Maccura Biotechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Maccura Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Maccura Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Maccura Biotechnology performance evaluation
Checking the ongoing alerts about Maccura Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Maccura Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Maccura Biotechnology generated a negative expected return over the last 90 days | |
| About 40.0% of the company shares are owned by insiders or employees |
- Analyzing Maccura Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Maccura Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining Maccura Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Maccura Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Maccura Biotechnology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Maccura Biotechnology's stock. These opinions can provide insight into Maccura Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Maccura Stock analysis
When running Maccura Biotechnology's price analysis, check to measure Maccura Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maccura Biotechnology is operating at the current time. Most of Maccura Biotechnology's value examination focuses on studying past and present price action to predict the probability of Maccura Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maccura Biotechnology's price. Additionally, you may evaluate how the addition of Maccura Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |